Search details
1.
Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity.
Immunity
; 55(2): 308-323.e9, 2022 02 08.
Article
in English
| MEDLINE | ID: mdl-34800368
2.
Deciphering the immunopeptidome in vivo reveals new tumour antigens.
Nature
; 607(7917): 149-155, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35705813
3.
Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.
Breast Cancer Res
; 14(6): R155, 2012 Dec 07.
Article
in English
| MEDLINE | ID: mdl-23216814
4.
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.
J Immunother Cancer
; 10(7)2022 07.
Article
in English
| MEDLINE | ID: mdl-35820727
5.
You are the most valuable reagent in the lab: mental health before and during the pandemic.
Mol Biol Cell
; 32(19): 1795-1796, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-34463523
6.
Tissue Site and the Cancer Immunity Cycle.
Trends Cancer
; 5(10): 593-603, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31706507
7.
Dia1-dependent adhesions are required by epithelial tissues to initiate invasion.
J Cell Biol
; 217(4): 1485-1502, 2018 04 02.
Article
in English
| MEDLINE | ID: mdl-29437785
8.
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer.
Oncotarget
; 7(18): 26259-74, 2016 May 03.
Article
in English
| MEDLINE | ID: mdl-27036029
9.
DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
Cancer Prev Res (Phila)
; 3(2): 190-201, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-20028875
Results
1 -
9
de 9
1
Next >
>>